Immune effector cells via secreted factors and direct cell contact

The term Immune effector cells via secreted factors and direct cell contact describes a complex physiological mechanism of the immune system rather than a single molecular target. It refers to the dual-modality approach used by cells such as cytotoxic T lymphocytes (CTLs) and Natural Killer (NK) cells to eliminate infected or neoplastic cells (Abbas et al., Cellular and Molecular Immunology, 2021). Direct cell contact involves the formation of an immunological synapse and the delivery of cytotoxic payloads like perforins and granzymes, or the activation of death receptors such as FAS (Janeway et al., Immunobiology, 2001). Secreted factors include a variety of cytokines, most notably Interferon-gamma and Tumor Necrosis Factor, which modulate the microenvironment and induce apoptosis in target cells (NCI Dictionary of Cancer Terms, 2023). While modern immunotherapies like checkpoint inhibitors and CAR-T cells are designed to harness these effector mechanisms, the phrase itself encompasses hundreds of distinct receptors and signaling molecules. Consequently, it is considered an incorrect designation for a specific therapeutic target in a drug discovery context.

Other names

Immune effector cell-mediated immunityCell-mediated cytotoxicityEffector immune responseT-cell mediated killing

Not applicable as this refers to a broad physiological process involving multiple cell types and molecular pathways rather than a single drug target.